Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, Segev DL. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311:579–86.
Article CAS PubMed PubMed Central Google Scholar
Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. How do living kidney donors develop end-stage renal disease? Am J Transpl. 2009;9:2514–9.
Transplantation JSfCR. Annual progress report, for clinical kidney transplantation in 2022 and follow-up survey results. Ishoku (Transplant). 2023;2023(58):189–208.
Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, et al. Membranous nephropathy. Nat Rev Dis Primers. 2021;7:69.
Morioka F, Nakatani S, Mori K, Naganuma T, Yamasaki T, Uedono H, et al. New-onset kidney biopsy-proven membranous nephropathy induced end-stage kidney disease in a living donor. Intern Med. 2024;63:2537–41.
Article PubMed PubMed Central Google Scholar
Murata M, Takeda A, Ootsuka Y, Shinjo H, Ito C, Watanabe Y, et al. Study of glomerulopathy in donors after kidney transplantation. Nephron. 2020;144(Supplement 1):86–90.
Article CAS PubMed Google Scholar
Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022;18:466–78.
Article CAS PubMed Google Scholar
Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, et al. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int. 2023;104:1092–102.
Article CAS PubMed Google Scholar
Sethi S, Fervenza FC. Membranous nephropathy-diagnosis and identification of target antigens. Nephrol Dial Transplant. 2024;39:600–6.
Article CAS PubMed Google Scholar
Efe O, So PNH, Anandh U, Lerma EV, Wiegley N. An updated review of membranous nephropathy. Indian J Nephrol. 2024;34:105–18.
Article PubMed PubMed Central Google Scholar
Caza TN, Hassen SI, Dvanajscak Z, Kuperman M, Edmondson R, Herzog C, et al. NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int. 2021;99:967–76.
Article CAS PubMed Google Scholar
Andeen NK, Kung VL, Avasare RS. NELL1 membranous nephropathy: clinical associations provide mechanistic clues. Front Nephrol. 2024;4:1323432.
Article PubMed PubMed Central Google Scholar
Sethi S. The many faces of NELL1 MN. Clin Kidney J. 2023;16:442–6.
Article CAS PubMed Google Scholar
Hu X, Wang G, Cheng H. Specific antigens in malignancy-associated membranous nephropathy. Front Med (Lausanne). 2024;11:1368457.
Hyodo T, Hara S, Goto S, Fujii H, Nishi S, Yoshimoto A, Itoh T. Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis. Virchows Arch. 2024.
Yagisawa T, Mieno M, Ichimaru N, Morita K, Nakamura M, Hotta K, et al. Trends of kidney transplantation in Japan in 2018: data from the kidney transplant registry. Ren Replace Ther. 2019;5:1–14.
Hanafusa N, Abe M, Joki N, Hoshino J, Wada A, Kikuchi K, et al. Annual dialysis data report 2021, Japanese Society for Dialysis Therapy (JSDT) renal data registry. Ren Replace Ther. 2024;10:78.
von Haxthausen F, Reinhard L, Pinnschmidt HO, Rink M, Soave A, Hoxha E, Stahl RAK. Antigen-specific IgG subclasses in primary and malignancy-associated membranous nephropathy. Front Immunol. 2018;9:3035.
Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574–9.
Article CAS PubMed Google Scholar
Qu Z, Liu G, Li J, Wu LH, Tan Y, Zheng X, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27:1931–7.
Article CAS PubMed Google Scholar
Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, et al. Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol. 2019;30:1123–36.
Article CAS PubMed PubMed Central Google Scholar
Sethi S, Debiec H, Madden B, Vivarelli M, Charlesworth MC, Ravindran A, et al. Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int. 2020;98:1253–64.
Article CAS PubMed Google Scholar
Sethi S, Madden B, Debiec H, Morelle J, Charlesworth MC, Gross L, et al. Protocadherin 7-associated membranous nephropathy. J Am Soc Nephrol. 2021;32:1249–61.
Comments (0)